as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
1.05%
Downside
6.08%
Upside
52 Week's Low
52 Week's High
11.76%
Downside
67.78%
Upside
Check Adma Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.8B
EPS (TTM)
0.565
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.08%
PE Ratio (TTM)
18.95
Industry PE ratio
10.127857142857144
P/B Ratio
18.9529
PEG Ratio
0EBITDA
163.6M
Revenue (TTM)
474.2M
Profit Margin
44.06%
Return On Equity TTM
71.23%
Track how Adma Biologics Inc P/E has moved over time to understand its valuation trends.
Adma Biologics Inc in the last 5 years
Lowest (32.88x)
March 31, 2025
Industry (10.13x)
September 15, 2025
Today (18.95x)
September 15, 2025
Highest (59.92x)
June 30, 2024
Today’s Price to Earnings Ratio: 18.95x
Compare market cap, revenue, PE, and other key metrics of Adma Biologics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.8B | NA | 18.95 | 44.06% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Adma Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adma Biologics Inc investment value today
Current value as on today
₹89,562
Returns
Returns from Adma Biologics Inc Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Adma Biologics Inc. Average target price of $29.06
Get share price movements and forecasts by analysts on Adma Biologics Inc.
What analysts predicted
47.35%UPSIDE
Target Price
$29.06
Current Price
$15.3
Analyzed by
10 Analysts
Target
$29.06
Adma Biologics Inc target price $29.06, a slight upside of 47.35% compared to current price of $15.3. According to 10 analysts rating.
Investment in Adma Biologics Inc Shares on INDmoney has dropped by -42.85% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Adma Biologics Inc Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 26.90M → 34.21M (in $), with an average increase of 21.4% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 114.80M → 121.98M (in $), with an average increase of 5.9% per quarter
Best in 3 Years
In the last 3 years, ADMA has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 86.5%
Price Dip
In the last 3 months, ADMA stock has moved down by -22.6%
Organisation | Adma Biologics Inc |
Headquarters | 465 State Route 17, Ramsey, NJ, United States, 07446 |
Industry | Health Technology |
CEO | Mr. Adam S. Grossman |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Adam S. Grossman | Co-Founder, President, CEO & Director |
Dr. Jerrold B. Grossman D.P.S., Ph.D. | Co-Founder & Vice Chairman of the Board |
Mr. Brad Tade | CFO & Treasurer |
Ms. Kaitlin Kestenberg | COO & Senior VP of Compliance |
Mr. Michael Goldstein | General Counsel |
Mr. John Hafl | Executive Director of Sales |
Ms. Cindy Petersen | Vice President of Human Resources |
Mr. Skyler Bloom | Senior Director of Business Development & Corporate Strategy |
Adma Biologics Inc share price today is $15.3 as on at the close of the market. Adma Biologics Inc share today touched a day high of $16.23 and a low of $15.14.
Adma Biologics Inc share touched a 52 week high of $25.67 on and a 52 week low of $13.5 on . Adma Biologics Inc stock price today i.e. is closed at $15.3,which is 40.40% down from its 52 week high and 13.33% up from its 52 week low.
Adma Biologics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Adma Biologics Inc (ADMA) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Adma Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Adma Biologics Inc share’s latest price of $15.3 as on September 16, 2025 at 1:29 am IST, you will get 0.6536 shares of Adma Biologics Inc. Learn more about
fractional shares .